United States

Texas

Name of AuthorInstitutional Affiliation
Anderson-Reitz LBaylor-Charles A. Sammons Cancer Center, Dallas, TX 75246, USA. lowell.anderson-reitz@usoncology.com
Berrios-Rivera JPDivision of Epidemiology, University of Texas School of Public Health, Houston, Texas 77030, USA.
Cabanillas MEDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. mcabani@mdanderson.org
Du XLDepartment of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.
Fanale MADepartment of Lymphoma/Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. mfanale@mdanderson.org
Fayad LDepartment of Lymphoma/Myeloma, University of Texas, MD Anderson Cancer Center, Box # 429, Houston, TX 77030, USA.
Keating MJDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Lee STThe University of Texas M. D. Anderson Cancer Center, Department of Lymphoma and Myeloma, Division of Cancer Medicine, 1515 Holcombe Blvd, Unit 903, Houston, TX, 77030 USA. stlee@mdanderson.org
Neelapu SSThe University of Texas M. D. Anderson Cancer Center, Department of Lymphoma and Myeloma, Division of Cancer Medicine, 1515 Holcombe Blvd, Unit 903, Houston, TX, 77030 USA.
Romaguera JThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 429, Houston, TX 77030-4009, USA.
Tsimberidou AMDepartment of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. atsimber@mdanderson.org
Wang MThe University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Box 429, Houston, TX 77030-4009, USA. miwang@mdanderson.org
Younes ADepartment of Lymphoma/Myeloma, University of Texas, MD Anderson Cancer Center, Box # 429, Houston, TX 77030, USA.